These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17997267)

  • 21. Examining the use of visual performance feedback in drug treatment court.
    Festinger DS; Dugosh KL; Della Porta JM
    Exp Clin Psychopharmacol; 2018 Feb; 26(1):85-93. PubMed ID: 29389171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis.
    Bernard CL; Rao IJ; Robison KK; Brandeau ML
    PLoS Med; 2020 Oct; 17(10):e1003239. PubMed ID: 33048929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Criminal justice referral and incentives in outpatient substance abuse treatment.
    DeFulio A; Stitzer M; Roll J; Petry N; Nuzzo P; Schwartz RP; Stabile P
    J Subst Abuse Treat; 2013 Jul; 45(1):70-5. PubMed ID: 23433822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug treatment courts and the disease paradigm.
    Nolan JL
    Subst Use Misuse; 2002; 37(12-13):1723-50. PubMed ID: 12487240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the substance abuse and crime prevention act: treatment clients and program types during the first year of implementation.
    Evans E; Longshore D
    J Psychoactive Drugs; 2004 May; Suppl 2():165-74. PubMed ID: 15279129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are judicial status hearings a "key component" of drug court? Six and twelve months outcomes.
    Marlowe DB; Festinger DS; Dugosh KL; Lee PA
    Drug Alcohol Depend; 2005 Aug; 79(2):145-55. PubMed ID: 16002024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Juvenile drug treatment courts in the United States: initial lessons learned and issues being addressed.
    Cooper CS
    Subst Use Misuse; 2002; 37(12-13):1689-722. PubMed ID: 12487239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiles of criminal-justice clients in drug treatment: implications for intervention.
    Kline A
    Addict Behav; 1997; 22(2):263-8. PubMed ID: 9113220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Criminal justice responses to drug related crime in Scotland.
    Malloch M; McIvor G
    Int J Drug Policy; 2013 Jan; 24(1):69-77. PubMed ID: 22809480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adapting judicial supervision to the risk level of drug offenders: discharge and 6-month outcomes from a prospective matching study.
    Marlowe DB; Festinger DS; Dugosh KL; Lee PA; Benasutti KM
    Drug Alcohol Depend; 2007 May; 88 Suppl 2(Suppl 2):S4-13. PubMed ID: 17071020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use.
    Iguchi MY; Belding MA; Morral AR; Lamb RJ; Husband SD
    J Consult Clin Psychol; 1997 Jun; 65(3):421-8. PubMed ID: 9170765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Substance Abuse and Crime Prevention Act: client characteristics, treatment completion and re-offending three years after implementation.
    Evans E; Longshore D; Prendergast M; Urada D
    J Psychoactive Drugs; 2006 Nov; Suppl 3():357-67. PubMed ID: 17357527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug courts: current issues and future perspectives.
    Cooper CS
    Subst Use Misuse; 2003; 38(11-13):1671-711. PubMed ID: 14582574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the level of Service Inventory-Revised to improve assessment and treatment in drug court.
    Guastaferro WP
    Int J Offender Ther Comp Criminol; 2012 Aug; 56(5):769-89. PubMed ID: 21693454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment inside the drug treatment court: the who, what, where, and how of treatment services.
    Taxman FS; Bouffard J
    Subst Use Misuse; 2002; 37(12-13):1665-88. PubMed ID: 12487238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do noncontingent vouchers increase drug use?
    Schroeder JR; Gupman AE; Epstein DH; Umbricht A; Preston KL
    Exp Clin Psychopharmacol; 2003 Aug; 11(3):195-201. PubMed ID: 12940498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. California drug courts: outcomes, costs and promising practices: an overview of Phase II in a statewide study.
    Carey SM; Finigan M; Crumpton D; Waller M
    J Psychoactive Drugs; 2006 Nov; Suppl 3():345-56. PubMed ID: 17357526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining the Impact of Prior Criminal Justice History on 2-Year Recidivism Rates: A Comparison of Drug Court Participants and Program Referrals.
    Shannon LM; Jackson Jones A; Newell J; Neal C
    Int J Offender Ther Comp Criminol; 2018 Feb; 62(2):291-312. PubMed ID: 27125834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of substance use disorder treatment as an alternative to imprisonment.
    Virtanen S; Aaltonen M; Latvala A; Forsman M; Lichtenstein P; Chang Z
    BMC Psychiatry; 2024 Apr; 24(1):260. PubMed ID: 38589822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.